Abstract
Background Cognitive function measured by digital clock drawing test (dCDT) has drawn attention for their precision, automation, and reproductivity. However, the relationship between digital cognitive metrics and biological aging is lacking.
Methods We conducted association analyses between cognitive function measured by dCDT and biological aging metrics quantified by five DNA methylation (DNAm) age metrics (Horvath, Hannum, GrimAge, PhenoAge, and DunedinPACE) in the Framingham Heart Study (FHS). We conducted linear regression to investigate the association between cognitive functions (global cognitive function and four sub-domain functions) and DNAm age acceleration, adjusting for covariates. We used a false discovery rate (FDR) < 0.05 for significance.
Results Among the 1,798 FHS participants (mean age 65±13, 53% women), we found that a lower dCDT total score is associated with DNAm age acceleration. Larger magnitudes of associations were observed in older participants (≥ 65 years). The dCDT total score showed the strongest association with the DundinPACE in the pooled sample (beta = −2.1, FDR = 0.0004), the younger (beta = −1.9, FDR = 0.02), and older age group (beta = −2.2, FDR = 0.01). The dCDT total score was significantly associated with age acceleration estimated by Horvath (beta=-1.9, FDR =0.01) and PhenoAge (beta=-2.5, FDR=0.01) in older participants while not in the pooled sample or younger participants (<65 years). In sub-domain cognitive functions, we found that simple motor function was significantly associated with DunedinPACE (FDR = 0.005) in both age groups and associated with GrimAge (FDR = 0.05 in older age group), indicating the deterioration in various organ systems may particularly impact this domain.
Discussion Our findings suggest that cognitive function measured by a digital clock drawing test is associated with DNAm age acceleration in middle-aged and older participants in the FHS, potentially shedding light on the epigenetic mechanisms underlying digitally measured cognitive function.
Competing Interest Statement
Conflict of Interest Dr. Au is a scientific advisor to Signant Health and Novo Nordisk. The other authors have no conflict of interest.
Funding Statement
This work was supported by the National Heart, Lung, and Blood Institute contract (N01-HC-25195; HHSN268201500001I) and grants from the National Institute on Aging (AG008122, AG062109, AG068753).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of Boston University Medical Campus gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors and the Framingham Heart Study. The data used in this study could be requested through an application to the Framingham Heart Study (https://www.framinghamheartstudy.org/fhs-for-researchers/).
